RA Capital Management is a Boston-based investment firm that provides multi-stage capital to public and private healthcare, life sciences, and planetary health companies. The firm supports management teams from early seed rounds to later financings, seeking to drive value through scientific and clinical data, product development, and commercialization. It complements capital with value-added services such as board representation, executive recruitment, and market intelligence through its TechAtlas research platform. The company also operates Raven, a healthcare incubator that helps entrepreneurs build biomedical ventures, and emphasizes a collaborative, data-driven approach and long-term relationships. RA Capital pursues social responsibility by advocating for affordable medicines and industry advancement, and it invests across U.S. and European opportunities, including early-stage and growth-stage rounds.

MassVentures is a Massachusetts-based venture firm founded in 1978 that provides seed and early-stage capital to high-growth startups as they move from concept to commercialization. Originally formed as a quasi-public corporation, it is governed by an independent board and operates to support the state’s innovation ecosystem. The firm focuses on early-stage deep tech and technology-enabled sectors, including quantum computing, clean energy, AI, biotech, information technology, healthcare, cybersecurity, e-commerce, mobile, manufacturing, and robotics, offering funding, mentorship, and strategic guidance to help ideas become viable businesses. Through MV Capital, MassVentures provides venture funding and non-dilutive grants, and it runs programs such as MV Accelerate and MV Spinouts in partnership with academic institutions. Over its history, MassVentures has supported hundreds of startups in Massachusetts and helped attract follow-on capital, contributing to a thriving regional innovation ecosystem with a strong emphasis on inclusive, high-performing teams.

General Catalyst is a venture capital firm founded in 2000, based in San Francisco with offices in Cambridge, Massachusetts, that funds and mentors startups from seed to growth stages. It focuses on enabling innovation across sectors such as consumer, enterprise software, fintech, healthcare, crypto, and artificial intelligence by providing capital, strategic guidance, and network support to help portfolio companies scale and create lasting value.

Atlas Venture is a Cambridge-based venture capital firm with a 30-year history of building life sciences companies. Founded in 1980, it focuses on early-stage opportunities in biotechnology, biopharmaceuticals, diagnostics, medical devices, and related life sciences, as well as technology sectors. The firm uses a seed-led venture creation approach and often leads initial rounds, providing strategic guidance and board representation to portfolio companies. Its portfolio has included the development of more than 25 medicines and the launch of eight startups through its incubator program, and it has facilitated 43 IPOs and 39 M&A exits. Atlas operates with a global reach across the United States and Europe, supporting life science entrepreneurs in translating scientific advances into therapies and commercial opportunities.

Morningside Group is a venture capital firm founded in 1986, originally established as a family office for the Chan family, and is based in the greater Boston area. The firm makes venture investments in companies with novel science and technology, pursuing a long-term, patient approach to company-building and emphasizing ethical practices. Its investment focus spans life sciences, digital health, artificial intelligence, materials science, and information technology. In addition to its investment activities, Morningside supports charitable initiatives in education, research, and healthcare, with partnerships including the Harvard T.H. Chan School of Public Health, UMass Chan Medical School, and the MIT Morningside Academy for Design.

Alumni Ventures is a venture capital firm founded in 2014 and based in Manchester, New Hampshire. It connects accredited individual investors with startup deals and co-invests alongside established venture capital firms across multiple stages, from seed to growth. The firm provides access to diversified portfolios through funds, syndicates, and investing clubs, supported by a large network of community members and individual investors. It invests across sectors and geographies, with a focus on transparency and due diligence in collaborative investments with leading firms such as Andreessen Horowitz, Sequoia, and Y Combinator. Alumni Ventures operates internationally with offices in New York, Boston, Menlo Park, Chicago, London, and Tokyo and has raised substantial capital to back founders with strategic capital and resources.

Flagship Pioneering is a Cambridge, Massachusetts-based venture builder that conceives, creates, resources, and scales first-in-category companies in health, biotechnology, and sustainability. It turns early scientific breakthroughs into durable platforms and enterprises by combining scientific discovery with entrepreneurial leadership and capital management, pursuing transformative outcomes through an evolutionary approach. With more than 25 years of experience, Flagship builds ecosystems that connect science, startups, and collaboration across partners. Notable portfolio companies include Moderna, Tessera Therapeutics, Generate Biomedicines, Inari Agriculture, Quotient Therapeutics, Lila Sciences, and Serif Biomedicines, reflecting a focus on pioneering medicines, intelligence, and preemptive health. The firm collaborates with major partners such as Genentech, Pfizer, GSK, Novo Nordisk, and Montai Therapeutics and engages in technology partnerships like AWS to accelerate discovery. Flagship emphasizes global health impact and disruptive science, fostering programs and opportunities through initiatives such as the Flagship Fellowship.

Mission BioCapital is a life sciences venture capital firm established in 2009 and based in Cambridge, Massachusetts, that funds early-stage biotechnology companies and supports them through clinical development. The firm emphasizes mentorship and practical assistance, offering entrepreneurs access to laboratory space, incubator networks, and programs designed to accelerate progress and secure follow-on funding. Its approach combines capital with hands-on guidance across discovery, development, and commercialization, leveraging a history of supporting dozens of startups. Through a broad ecosystem in the United States and Europe, Mission BioCapital aims to translate scientific discoveries into tangible solutions by pairing funding with operational support, expert advice in areas such as drug discovery, legal, and accounting, and strategic mentorship to help portfolio companies reach milestones and attract subsequent investment.

Founder Collective is a venture capital firm established in 2009 with headquarters in Cambridge, Massachusetts and an office in New York. It focuses on seed and pre-seed technology investments across sectors, backing startups from concept through early outcomes. Built by founders, the firm prioritizes long-term, aligned partnerships and emphasizes founder alignment and capital efficiency over hype, aiming to create value through disciplined, founder-friendly support. Though it maintains a global investment footprint, it has a noted emphasis on East Coast opportunities and information technology related ventures.

New Enterprise Associates is a United States-based venture capital firm founded in 1977 and headquartered in Menlo Park, California. It invests in technology and healthcare companies across multiple stages, from seed to growth and IPO, and provides strategic support in product development and market expansion. The firm targets sectors including software, AI, consumer technology, digital health, life sciences, and energy technology, and pursues opportunities worldwide. NEA emphasizes long-term partnerships with founders, drawing on domain expertise and a broad network to help portfolio companies scale. It maintains a diverse portfolio across the United States, Asia and other regions, reflecting a global approach to venture investing.

Accomplice is a seed-led venture capital firm based in Cambridge, Massachusetts, focused on early-stage technology startups. It specializes in cybersecurity, esports, data analytics, SMB software, emerging hardware platforms, and marketplaces. The firm emphasizes a community-driven approach, leveraging networks such as AngelList to identify and fund founders and supporting them through collaborative programs. While most investments are in the Boston area, Accomplice backs companies across the United States, Canada, and the European Union. Originating as Atlas Venture, the technology group was renamed Accomplice in 2014, establishing a prominent early-stage presence in New England.

Founded in 1985, The Invus Group is a global private equity firm that partners with entrepreneurs, founders and management teams across the company lifecycle. Blending a family-office approach with multi-strategy investing, it supports transformative growth in sectors including consumer products and services, technology, life sciences, software, agtech, industrials, education and medical devices. The firm pursues long-term value creation through strategic insight, capital and execution, investing in companies from early stages to mature businesses and providing both lead investments and co-investments in private transactions worldwide. It maintains a global footprint with offices in New York, London, Paris and Hong Kong and has a flexible structure designed to align incentives with partners over time.

Alexandria Venture Investments is the strategic venture capital arm of Alexandria Real Estate Equities. It provides seed through growth capital to life science and technology companies developing breakthrough therapies, diagnostics, research tools, agrifoodtech, agtech, digital health, and related platforms. Backed by the parent company’s industry experience and scientific advisory network, the firm leverages long-standing relationships and domain expertise to support early to growth-stage ventures aiming to translate scientific advances into practical healthcare and technology solutions.

OrbiMed is a global healthcare investment firm based in New York that funds companies across the healthcare spectrum. It uses multiple strategies, including private equity for startups and growth-stage companies, private credit and royalty financing for intellectual property and medical diagnostics, and public equity investments. The firm targets biopharmaceuticals, biotechnology, medical devices, diagnostics, digital health, and health IT, supporting development of new therapies and health technologies. OrbiMed operates internationally with offices in major markets and manages substantial assets across public and private investments, staffed by a team of professionals to identify opportunities and support portfolio companies.

ARCH Venture Partners is a Chicago-based venture capital firm founded in 1986 that concentrates on science-driven startups, especially in life sciences, biotechnology, healthcare, and related technologies. It backs companies co-founded by scientists and entrepreneurs and supports commercialization of innovations developed at academic research institutions and national laboratories. The firm takes a long-term, hands-on approach, leveraging its network to assist portfolio companies from inception to market realization and to build transformative enterprises. ARCH has raised ten venture funds totaling over $3 billion and has invested in more than 150 companies worldwide, reflecting a focus on strategic value creation and governance.

F-Prime Capital is a venture capital firm based in Cambridge, Massachusetts, with a global portfolio of over 400 companies focused on healthcare and technology. It backs therapeutics, medtech, and healthtech and services as well as enterprise software, fintech, frontier tech and crypto, investing across the Americas, Europe and Asia and across stages from early to later as opportunities arise. The firm relies on a multidisciplinary team of scientists, engineers, physicians, operators and investors to help portfolio companies accelerate scalable growth and translate bold ideas into breakthroughs. With more than 50 years in operation and about $4.8 billion under management, F-Prime Capital provides strategic guidance and deep domain expertise to support ambitious teams worldwide.

Eli Lilly and Company is a global pharmaceutical company engaged in the discovery, development, manufacturing, and marketing of medicines for human health. It operates manufacturing facilities in the United States, Puerto Rico, and about 25 other countries, with products sold in approximately 135 countries. The company also conducts research in animal health, including efforts to improve disease treatments in animals and the efficiency of animal food production. Its therapeutic focus includes neuroscience, cardiometabolic diseases, cancer, and immunology, with a portfolio of medicines addressing conditions such as cancer, diabetes, autoimmune disorders, and neurodegenerative diseases. Eli Lilly and Company is committed to high standards of safety and quality in manufacturing and to expanding access to therapies through global operations and patient support initiatives.

Spark Capital is a venture capital firm founded in 2005 with offices in San Francisco, Boston, and New York. It invests in early-stage and growth companies across a wide range of sectors, including consumer, software, media, fintech, education technology, and internet services, supporting founders who pursue ambitious ideas and seek product-led strategies. The firm is known for backing prominent companies such as Twitter, Discord, Oculus, Warby Parker, Tumblr, Niantic, and others, reflecting a willingness to back disruptive teams and markets. Spark Capital emphasizes a founder-centric approach, prioritizing listening, product-market fit, independence of thought, and resilience, and aims to help portfolio companies scale on their own terms. By partnering across stages and geographies, the firm seeks to build enduring, value-driving businesses in the United States and beyond.

Matrix Partners is a venture capital firm founded in 1977 that backs early‑stage to growth technology companies. Based in San Francisco with a global footprint, the firm invests across sectors such as software, B2B, AI, fintech, consumer, healthtech, infrastructure, and hardware, supporting companies from idea through Series A and beyond. Its approach combines hands‑on guidance from a team of former founders and operators who help with product strategy, go‑to‑market, and talent recruitment. Matrix maintains regional arms, including Matrix Partners China and Matrix Partners India, to partner with local entrepreneurs while pursuing cross‑border opportunities. The firm has a long track record of notable portfolio companies and exits, reflecting a focus on building enduring, scalable businesses through active collaboration with founders.

North Bridge Venture Partners is a venture capital firm based in Needham, Massachusetts. Founded in 1993, it provides seed-to-growth financing to US-based companies across software, open source, cloud computing, e-commerce, big data, analytics, and mobile, with extensions into digital media, healthcare, and materials production. The firm backs exceptional entrepreneurs whose ideas have the potential to disrupt markets, aiming to transform early-stage concepts into companies and those companies into market leaders. It offers capital across stages—from seed through growth equity—supporting companies as they scale and expand domestically. North Bridge concentrates on building portfolio companies that leverage technology to drive scalable, data-driven businesses, often partnering with management teams to accelerate product development, customer acquisition, and geographic expansion.

Casdin Capital is an investment firm focused on life sciences and healthcare. Founded in 2012 by Eli Casdin and based in New York, it seeks opportunities across the life sciences spectrum, including biotechnology, digital health, oncology, agtech, and healthcare services. The firm pursues early- to late-stage private investments and, at times, long-short equity strategies, leveraging data-driven insights, molecular information, and precision medicine to identify transformative opportunities. It emphasizes patient capital, disciplined investing, and strong collaborations to support companies advancing diagnostics, therapeutics, and sustainable solutions. By capturing and processing data to unlock breakthroughs, Casdin Capital backs teams with the potential to transform modern medicine.

Khosla Ventures is a California-based venture capital firm founded in 2004 that provides capital and strategic support to technology-driven startups across early- to late-stage cycles. It pursues opportunities in AI, digital health, healthcare technologies, sustainability, fintech, consumer and enterprise technology, and other frontier areas, focusing on innovative business models and world-class teams. The firm emphasizes a contrarian, long-term approach and seeks to help entrepreneurs address meaningful societal and economic challenges through science, technology, and design.

Deerfield Management is a New York-based healthcare investment firm established in 1994. It manages investments across public and private markets in healthcare products and services, including therapeutics, medical devices, diagnostics, digital health, and health services. The firm combines capital deployment with research and strategic intelligence through Deerfield Intelligence and supports innovation via Deerfield Discovery and Development (3DC) and a philanthropic foundation focused on education, healthcare access, and health outcomes.

Hyperplane Venture Capital is a Boston-based early-stage venture capital firm that invests in technology companies, particularly those applying artificial intelligence, machine learning, data-centric approaches, cloud computing, automation, and related fields. The firm backs exceptional founders and supports portfolio companies through multiple funding rounds, often providing early checks and ongoing guidance as they scale. Hyperplane emphasizes building solutions at the nexus of perception, communication, intelligence, and insight, and seeks opportunities where AI and related technologies can transform industries.

Venrock is a venture capital firm founded in 1969 as the venture capital arm of the Rockefeller family. It focuses on technology and healthcare, investing in seed and early-stage companies in the United States and pursuing life sciences and emerging technologies. The firm provides funding and strategic guidance to entrepreneurs with the aim of building enduring, high-growth companies. Its portfolio has included notable technology and biotech names such as Apple, Illumina, Gilead Sciences, and DoubleClick. Venrock maintains offices in Palo Alto, California, and New York, and emphasizes long-term partnerships with founders to accelerate innovation.

.406 Ventures is a Boston-based venture capital firm that backs early-stage information technology and services companies, with emphasis on IT security and infrastructure, cloud and data, SaaS, cybersecurity, digital health, AI, fintech, and healthcare IT. It typically serves as lead investor in seed and Series A rounds, with initial investments of 2 to 5 million and total commitments around 6 to 10 million per company, and pursues board representation. The firm concentrates on the Northeast United States and leverages a veteran team of entrepreneurs and operators to provide strategic guidance, networks, and hands-on support to help portfolio companies grow and scale.

SV Health Investors is a United States-based private investment firm focusing on healthcare and life sciences. Founded in 1993 (formerly SV Life Sciences), it operates across venture capital, growth equity and private equity, backing innovative therapeutics, biotechnology, medtech and healthcare services companies in North America and Western Europe. The firm provides capital and strategic support to entrepreneurs to build breakthrough companies, aiming to create value for patients and investors. With a global team of investment professionals and offices in Boston, San Francisco and London, SV Health Investors pursues opportunities across stages and geographies to advance medical innovation.

Third Rock Ventures is a Boston-based venture capital firm focused on building and funding life sciences companies. It invests in early-stage and growth-stage biotechnology, pharmaceuticals, medical devices, diagnostics, therapeutics, and health IT ventures. The firm provides substantial initial capital and seeks active involvement in portfolio companies, including leadership roles when appropriate, complemented by strategic collaborations to accelerate development. With offices in Boston and San Francisco, Third Rock supports American life science companies from inception through commercialization, emphasizing bold ideas that advance patient outcomes.

Northpond Ventures is a science-driven venture capital firm specializing in growth capital, headquartered in Bethesda, Maryland, with offices in San Francisco, California, and Cambridge, Massachusetts. Founded in 2018, it focuses on life sciences and technology sectors, including diagnostics, digital health, health tech, therapeutics, and artificial intelligence and machine learning. The firm backs growth-stage companies advancing biomedical research and technology-enabled healthcare, aiming to translate scientific advances into commercial solutions.

Pillar VC is an early-stage venture capital firm based in Boston, founded in 2016 by a group of CEOs who have built successful companies. The firm concentrates on technically driven startups, particularly in AI, biotech, and healthcare, and partners with founders from inception to help turn ideas into scalable businesses. Pillar VC emphasizes hands-on support, offering resources such as pitch deck templates, financial models, and investor outreach guidance to assist portfolio companies in navigating early-stage growth. Notable portfolio companies include Neural Magic, Abridge, PathAI, and Latent Labs. Pillar VC seeks to back breakthroughs that can redefine industries and improve patient outcomes.

Boston Seed Capital is a venture capital firm headquartered in the Boston area, with an office in Wellesley Hills, Massachusetts. Founded in 2010, it focuses on seed and early-stage investments in internet-enabled and technology-driven companies, including information technology, SaaS, cybersecurity, e-commerce, big data, marketplaces, esports, artificial intelligence and machine learning, as well as consumer goods and business services. The firm backs ventures across the United States, supporting early growth opportunities in consumer and technology sectors.

Mass General Brigham is an integrated academic health care system and Harvard Medical School teaching affiliate that comprises a network of hospitals and community health centers. It delivers a full continuum of patient care, advances biomedical research, and supports medical education, with a strong focus on health equity, workforce development, and community engagement. Founded more than 200 years ago, the system emphasizes innovation to improve patient outcomes and translates research into clinical practice across its member institutions.

SOSV is a global venture capital firm founded in 1995 and headquartered in New Jersey. The firm focuses on seed-to-growth investments in deep tech sectors, including biotech and life sciences, hardware and robotics, and cross-border software with emphasis on markets in Asia. It supports startups from early stages with investment capital as well as resources such as laboratories, collaborative spaces, and expert mentorship to accelerate product development and market traction. SOSV operates purpose-built programs to help portfolio companies raise follow-on funding, scale operations, and reach customers, often through structured matchmaking and access to a global network of investors. With a broad portfolio spanning hundreds of companies worldwide, SOSV aims to foster innovation, build vibrant entrepreneurial ecosystems, and contribute to sustainable technological advancement.

LaunchPad Venture Group is an angel investment group and venture capital firm based in Boston, Massachusetts, serving New England. Founded in 2001, it focuses on early-stage science and technology startups, providing both financial capital and strategic guidance. The firm emphasizes long-term relationships with founders and offers mentorship, drawing on a network of customers, service providers, partners, and potential subsequent financing. Its portfolio spans software, information technology, web and mobile applications, e-commerce, media and social platforms, healthcare IT, medical devices and diagnostics, networking and telecom, and clean-tech and renewable energy. The organization has invested more than 125 million in more than 150 companies, underscoring its hands-on approach to helping entrepreneurs scale.

Safar Partners is a Cambridge, Massachusetts-based venture capital firm founded in 2018 that backs seed- to growth-stage technology startups. The firm sources opportunities from the research ecosystem at MIT, Harvard, and the University of Rochester and focuses on platform technologies in cleantech and advanced materials, AI/IT and robotics, and life sciences and medical devices. Safar Partners leverages university connections and an advisory network to support portfolio companies through their lifecycle while integrating ESG considerations into its investment decisions. The firm aims to generate strong returns by funding early-stage ventures with the potential to scale technologically and commercially within the United States.

Beacon Angels is a Boston-based angel investment group founded in 2006 that backs early-stage and fast-growing companies in New England. The group targets investments typically ranging from $50,000 to $400,000, providing capital and support to entrepreneurs. Membership is limited to accredited investors who participate in a structured process with monthly meetings to review presentations and conduct deal screening. Beacon Angels coordinates deal flow through the Gust platform to connect members with investment opportunities and foster collaboration within the regional startup ecosystem.

Samsara BioCapital is a Palo Alto, California-based biotechnology investment firm founded in 2016 that focuses on supporting transformative therapeutics. The firm seeks opportunities in the healthcare sector across the United States and invests in biotechnology companies with the potential to advance patient care. With a team drawn from scientific, medical, and business backgrounds, Samsara BioCapital aims to accelerate the development and commercialization of innovative drugs through strategic partnerships and hands-on collaboration. The approach emphasizes rigorous scientific evaluation and value creation for portfolio companies, helping entrepreneurs turn ideas into therapies with meaningful patient impact.

CVP Management is a venture capital firm focused on early‑stage technology investments, including seed and early Series A rounds. It concentrates on information technology infrastructure with emphasis on software applications, internet, digital media, digital marketing, vertical SaaS, cloud, embedded software, mobile, and financial services technologies. The firm typically invests from $0.1 million to $1 million, and for seed and Series A rounds from $1 million to $3.5 million, in companies with an enterprise value around $5 million. It prefers to hold a seat on the portfolio company board and to invest in preferred stock. The firm funds companies located in the Northeast corridor, especially Boston, New York, and Toronto, and began operation on June 1, 1998, with headquarters in Cambridge, Massachusetts, and an additional office in Boston.

E14 Fund is a venture capital firm affiliated with MIT that backs scalable, deep-tech startups founded by MIT alumni, faculty, and students. The firm provides early-stage capital, typically in the range of one to five million dollars, with potential follow-on funding, and leverages the MIT ecosystem and a network of advisors to help portfolio companies move technologies from lab to market across fields such as artificial intelligence and computing, hardware and robotics, physics and materials, and biology. The organization actively supports the MIT startup community and connects entrepreneurs with investors, industry experts, and mentors to accelerate growth.

Underscore.VC is a Boston-based venture capital firm that funds early-stage technology startups across the United States, from pre-seed to Series A. The firm concentrates on enterprise software, AI/ML, vertical SaaS, insurtech, fintech, healthtech, commerce, and related infrastructure such as data storage, cloud software, and IoT. It operates with an open-source investing model and a Core Community of founders and executives from major tech companies, using profit-sharing with experts to align incentives with founders and support portfolio growth. The firm emphasizes its role as an early-stage partner connected to the Boston innovation ecosystem, providing strategic guidance and network access to help startups scale.

Novo Nordisk is a global healthcare company focused on discovering, developing, and delivering medicines for serious chronic diseases, with a core emphasis on diabetes care. The organization produces and distributes insulin and other therapies aimed at treating diabetes and related conditions, while investing heavily in scientific research and biopharmaceutical innovation. Through partnerships and sustained commitments to accessibility, Novo Nordisk seeks to improve patient outcomes and support health systems worldwide. The company operates across many markets, supported by its production of insulin pens and a broad portfolio addressing obesity, rare blood and endocrine disorders, and other chronic diseases. It pursues long-term social responsibility and sustainability as integral to its business model.

Logos Capital is a biotechnology-focused investment firm headquartered in San Francisco. The company applies disciplined, data-driven diligence across medical, scientific, and clinical disciplines to identify transformative therapies in healthcare. By combining in-house analytics with rigorous clinical evaluation, Logos Capital seeks to back life-changing therapeutics with strong value propositions. The firm emphasizes rigorous opportunity identification, thorough clinical trial underwriting, and proactive risk management, leveraging advanced analytics to predict trial outcomes and support informed investment decisions. Its approach aims to deliver compelling returns while contributing to patient outcomes by supporting companies with transformative technologies.

Lux Capital is a New York-based venture capital firm founded in 2000 that funds seed- and early-stage companies, with occasional growth investments, in science- and engineering-driven sectors. It backs ventures applying scientific research to commercial applications across artificial intelligence, biotechnology, advanced materials, electronics, aerospace and space technology, satellites, drones, robotics, synthetic biology, genomics, 3D printing, and related infrastructure. The firm provides capital alongside strategic input on product development, team building and long-term positioning, taking an active role to help translate complex innovations into scalable businesses. With offices in New York and Silicon Valley, Lux has helped launch more than 20 companies and manages several billion dollars in assets. It emphasizes deep scientific insight, cross-disciplinary collaboration, and an early-stage focus, aiming to connect portfolio companies with markets and industry leadership.

Refactor is a seed-stage venture firm based in Burlingame, California. Led by Zal Bilimoria as a solo general partner, it makes first-dollar investments of about 1–2 million per company across five funds totaling roughly 50 million in committed capital. The firm backs US-based hard-tech startups that build physical systems in aerospace, energy, bio, critical materials, immune health, and AI infrastructure, emphasizing durable moats, long development cycles, and sticky customer value. Its portfolio includes Solugen, Astranis, PathAI, Knowde, Clover Health, Berkeley Yeast, and others, with notable exits such as Uniform Teeth’s acquisition by Impress and Kip’s acquisition by Modern Health, and Clover Health’s public listing, illustrating a track record of meaningful exits and scale. Refactor originated as one of the first spinouts from a16z’s Bio Fund in 2015 and maintains a founder-first approach, inviting ambitious teams to pitch directly to Zal.

Fontinalis Partners is a Detroit-based venture capital firm focused on mobility and related technology. With offices in Detroit and Boston, it invests across the next-generation mobility ecosystem, spanning connected vehicles, data and analytics, intelligent infrastructure, location-based services, mobility transactions, and new mobility models such as car sharing and ride sharing. The firm partners with founders from pre-seed through growth rounds, adopting a stage-agnostic approach and often taking board seats to support strategic growth. It leverages extensive management experience, market access, and international networks to help portfolio companies scale globally within multi-modal transportation systems that may include road, rail, air, and maritime. Fontinalis also considers software, analytics, and cloud-based solutions that enable mobility. The firm emphasizes long-term partnerships and is not affiliated with Ford Motor Company.

Clean Energy Ventures is a venture capital firm focused on accelerating climate technology startups at seed and early stages. Based in Boston, Massachusetts, it backs companies developing advanced energy technologies and innovative business models to reduce greenhouse gas emissions. The firm invests in sectors such as energy storage, grid connectivity, renewable energy, clean transportation and related water and energy nexus initiatives, with a geographic focus on the United States and Canada and a broader reach into Europe and Israel. It complements capital with mentorship, strategic guidance and access to a wide network of industry experts to help portfolio companies scale and deploy transformative clean energy solutions.

Gutbrain Ventures is a Boston-based independent venture firm focused on investing in enterprise software. Descriptions from multiple sources place its founding in the 2010s (noting years such as 2011 and 2018), and identify Bob Davoli as its founder. The firm seeks paradigm-shifting opportunities by evaluating founders, people and technology, favoring passionate teams with disruptive ideas. It emphasizes long-term partnerships, offering strategic guidance and operational insights, with support across a company's lifecycle from early stages to exits and IPO candidacy, aiming to drive value across diverse sectors.

CRV, formerly Charles River Ventures, is an early-stage venture capital firm founded in 1970. Headquartered in Palo Alto, California, it maintains offices in Cambridge, Massachusetts, and Menlo Park, California. The firm targets seed to Series B investments across technology, consumer goods and healthcare in North America. CRV employs a hands-on, value-added approach, acting as a trusted partner to founders throughout a company's growth. As one of the oldest active venture firms, CRV has managed about $1.5 billion and supports portfolio companies with strategic guidance and operational insight to help them scale from inception onward.

Longwood Fund is a Boston-based venture capital firm that invests in science-based healthcare and biotechnology companies, aiming to develop novel solutions for medical problems. Founded in 2010, the firm supports early-stage research through to market commercialization by partnering with exceptional scientific co-founders and leveraging a deep network in the biotechnology ecosystem. Longwood Fund focuses on healthcare, pharmaceuticals, and life sciences, seeking to create patient impact and investor value by guiding portfolio companies from discovery to commercialization.

Andreessen Horowitz is a Menlo Park, California-based venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz. It backs technology companies across stages, from seed to growth, with a broad focus on software, cloud infrastructure, enterprise software and services, fintech, consumer internet, artificial intelligence, biotechnology, and life sciences applications at the intersection of computer science and biology. The firm emphasizes long-term support for entrepreneurs, offering capital and resources to help companies scale, and operates through multiple investment vehicles to fund early and later-stage opportunities. Its portfolio targets information technology, software-enabled businesses, and technology-enabled services, reflecting a commitment to innovation and leadership in American technology.